CPW
AZN icon

Cove Private Wealth’s AstraZeneca AZN Stock Holding History

Cove Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
2,031
+31
+2% +$5.83K 0.07% 163
2026
Q1 		$394K Hold
2,000
– – 0.09% 136
2025
Q4 		$368K Hold
2,000
– – 0.11% 123
2025
Q3 		$307K Hold
2,000
– – 0.1% 129
2025
Q2 		$280K Buy
+2,000
New +$280K 0.1% 131

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Cove Private Wealth's AZN Position: Q2 2026 in Review

Cove Private Wealth increased its AstraZeneca (AZN) stake by 1.6% in Q2 2026, buying an estimated $5.83K and bringing the position to 2,031 shares worth $385K. The position accounts for 0.07% of the portfolio, ranked #163.

Cove Private Wealth first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $394K in Q1 2026. 646 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cove Private Wealth held 2,031 shares of AstraZeneca worth $385K as of Q2 2026.
  • Cove Private Wealth bought 31 AstraZeneca shares in Q2 2026, an estimated $5.83K.
  • AstraZeneca made up 0.07% of Cove Private Wealth's portfolio in Q2 2026, its #163 holding.
  • Cove Private Wealth first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Cove Private Wealth's AstraZeneca position peaked at $394K in Q1 2026.
  • 646 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.